Keyphrases
Multiple Myeloma
100%
Direct Therapy
100%
Glucose Transporter 1 (GLUT1)
100%
Glucose Transporter 4 (GLUT4)
100%
GLUT8
100%
In Cancer
50%
Primary Cells
50%
Family Members
50%
Myeloma
50%
Myeloma Cells
50%
Glucose Consumption
50%
Glucose Transporter Family
50%
Therapeutic Potential
25%
Cell Surface
25%
Malignancy
25%
Inhibitory Effect
25%
Therapeutic Target
25%
Glucose Metabolism
25%
FDA-approved Drugs
25%
Therapeutic Strategies
25%
Cancer Knowledge
25%
Gene Expression Profiling
25%
Prognostic Implications
25%
Whole Cell
25%
Myeloid Cell leukemia-1 (Mcl-1)
25%
Ritonavir
25%
Glucose Supply
25%
Basal Glucose
25%
HIV Protease Inhibitors
25%
Normal Lymphocytes
25%
Targeted Compounds
25%
Transporter Inhibition
25%
Medicine and Dentistry
Multiple Myeloma
100%
Glucose Transporter 4
100%
Glucose Transporter
100%
Malignant Neoplasm
33%
Myeloma
33%
Glucose Intake
33%
Cell Surface
16%
Gene Expression Profiling
16%
Glucose Metabolism
16%
Ritonavir
16%
Myeloma Cell
16%
Myeloma Cell Line
16%
Human Immunodeficiency Virus Proteinase Inhibitor
16%
Cancer
16%
Cell Line
16%
Whole Cell
16%
Lymphocyte
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Glucose Transporter 4
100%
Multiple Myeloma
100%
Glucose Transporter
100%
Myeloma
66%
Malignant Neoplasm
33%
Ritonavir
16%
Human Immunodeficiency Virus Proteinase Inhibitor
16%
Diseases
16%
Immunology and Microbiology
Glucose Transporter
100%
Multiple Myeloma
100%
Cell Line
16%
Cell Surface
16%
Glucose Metabolism
16%
Human Immunodeficiency Virus
16%
Whole Cell
16%
Myeloma Cell Line
16%
Myeloma Cell
16%
Gene Expression Assay
16%
Lymphocyte
16%